Autophagy and biotransformation affect sorafenib resistance in hepatocellular carcinoma

Bibliographic Details
Title: Autophagy and biotransformation affect sorafenib resistance in hepatocellular carcinoma
Authors: Ruiqi Zheng, Shuang Weng, Jianping Xu, Zhuo Li, Yaru Wang, Zulihumaer Aizimuaji, Sheng Ma, Linlin Zheng, Haiyang Li, Wantao Ying, Weiqi Rong, Ting Xiao
Source: Computational and Structural Biotechnology Journal, Vol 21, Iss , Pp 3564-3574 (2023)
Publisher Information: Elsevier, 2023.
Publication Year: 2023
Collection: LCC:Biotechnology
Subject Terms: Sorafenib resistance, Autophagy, Biotransformation, Proteomics, HCC, PI3K/AKT/mTOR, Biotechnology, TP248.13-248.65
More Details: As sorafenib is a first-line drug for treating advanced hepatocellular carcinoma, sorafenib resistance has historically attracted attention. However, most of this attention has been focused on a series of mechanisms related to drug resistance arising after sorafenib treatment. In this study, we used proteomic techniques to explore the potential mechanisms by which pretreatment factors affect sorafenib resistance. The degree of redundant pathway PI3K/AKT activation, biotransformation capacity, and autophagy level in hepatocellular carcinoma patients prior to sorafenib treatment might affect their sensitivity to sorafenib, in which ADH1A and STING1 are key molecules. These three factors could interact mechanistically to promote tumor cell survival, might be malignant features of tumor cells, and are associated with hepatocellular carcinoma prognosis. Our study suggests possible avenues of therapeutic intervention for patients with sorafenib-resistance and the potential application of immunotherapy with the aim of improving the survival of such patients.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2001-0370
Relation: http://www.sciencedirect.com/science/article/pii/S2001037023002398; https://doaj.org/toc/2001-0370
DOI: 10.1016/j.csbj.2023.07.005
Access URL: https://doaj.org/article/3329a2098f694384bab273a36625cbbb
Accession Number: edsdoj.3329a2098f694384bab273a36625cbbb
Database: Directory of Open Access Journals
More Details
ISSN:20010370
DOI:10.1016/j.csbj.2023.07.005
Published in:Computational and Structural Biotechnology Journal
Language:English